Quality of life of patients suffering from chronic heart failure in Central Portugal
DOI:
https://doi.org/10.32385/rpmgf.v40i3.13711Keywords:
Chronic heart failure, General practice, Quality of lifeAbstract
Objectives: To evaluate chronic heart failure patient’s (PSCHF) quality of life (QoL) and to ascertain its relationship with context variables, comparing results between a generic and a specific QoL measurement tool.
Methods: Observational cross-sectional study, in a convenience sample of PSCHF in 2022, applying in self-fulfilment, with the investigator’s help if requested, the Euro Quality of Life Instrument – 5D (EQ5D-3l), the Kansas City Cardiomyopathy Questionnaire (KCCQ) and context variables in the General Practice/Family setting, in random days. Good or bad QoL according to the median value. EQ5D-3l was studied according to the Portuguese norm.
Results: A n=50 sample, n=29 (58%) women, mean age 74.1±8.9 years, was studied. Significant differences were found for the level of studies, inferior for women (p=0.019). For 40% of PSCHF, there was unfamiliarity of suffering from it. Spearman correlation, between the EQ-5D-3L score and the QoL-specific domain of KCCQ, was ρ=0.452, p=0.001, and between EQ-5D-3L score and the KCCQ Overall Summary Scale, ρ=0.556, p<0.001. For the arbitrary categories of the KCCQ Overall Summary Scale (p=0.189) and the EQ5D3l Portuguese norm (p=0.242), between genders, there was no difference, with females showing worse results.
Discussion: Instruments for measuring the therapeutic results and health consequences in PSCHF can change the actual paradigm of CHF treatment, QoL in PSCHF being one of those changes, and doctors becoming aware of PSCHF’s personal and social determinants.
Conclusion: Bad QoL was revealed for 70.0% of this sample and bad QoL for PSCHF for 50.0%, females with worse results. EQ-5D is easier to apply in a consultation ambiance, with only five questions, with KCCQ being more specific for PSCHF.
Downloads
References
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-726.
Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P. Polypharmacy definition and prevalence in heart failure: a systematic review. Heart Fail Rev. 2022;27(2):465-92.
Prazeres F, Santiago LM, Simões JA. Defining multimorbidity: from English to Portuguese using a Delphi technique. BioMed Res Int. 2015;2015:965025.
Ceia F, Fonseca C, Mota T, Morais H, Matias F, Sousa A, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICCA study. Eur J Heart Fail. 2002;4(4):531-9.
Fonseca C, Brás D, Araújo I, Ceia F. Heart failure in numbers: estimates for the 21st century in Portugal. Rev Port Cardiol. 2018;37(2):97-104.
Nieminen MS, Dickstein K, Fonseca C, Serrano JM, Parissis J, Fedele F, et al. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations. Int J Cardiol. 2015;191:256-64.
Comín-Colet J, Anguita M, Formiga F, Almenar L, Crespo-Leiro MG, Manzano L, et al. Health-related quality of life of patients with chronic systolic heart failure in Spain: results of the VIDA-IC study. Rev Esp Cardiol. 2016;69(3):256-71.
Johansson I, Joseph P, Balasubramanian K, McMurray JJ, Lund LH, Ezekowitz JA, et al. Health-related quality of life and mortality in heart failure: the Global Congestive Heart Failure Study of 23 000 patients from 40 countries. Circulation. 2021;143(22):2129-42.
Moradi M, Daneshi F, Behzadmehr R, Rafiemanesh H, Bouya S, Raeisi M. Quality of life of chronic heart failure patients: a systematic review and meta-analysis. Heart Fail Rev. 2020;25(6):993-1006.
van der Wal MH, Jaarsma T, Moser DK, Veeger NJ, van Gilst WH, van Veldhuisen DJ. Compliance in heart failure patients: the importance of knowledge and beliefs. Eur Heart J. 2006;27(4):434-40.
Almeida CS. Qualidade de vida no doente com insuficiência cardíaca [dissertation]. Coimbra: Faculdade de Medicina da Universidade de Coimbra; 2018. Available from: https://hdl.handle.net/10316/82291
Ferreira PL, Ferreira LN, Pereira LN. Contributos para a validação da versão portuguesa do EQ-5D [Contribution for the validation of the Portuguese version of EQ-5D]. Acta Med Port. 2013;26(6):664-75. Portuguese
Ferreira LN, Ferreira PL, Pereira LN, Oppe M. EQ-5D Portuguese population norms. Qual Life Res. 2014;23(2):425-30.
Nave-Leal E, Pais-Ribeiro J, Oliveira MM, Silva N, Soares R, Fragata J, et al. Psychometric properties of the portuguese version of the Kansas City cardiomyopathy questionnaire in dilated cardiomyopathy with congestive heart failure. Rev Port Cardiol. 2010;29(3):353-72.
Broeiro P. Literacia em saúde e utilização de serviços [Health literacy and use of health services]. Rev Port Med Geral Fam. 2017;33(1):6-8. Portuguese
Coelho A, Vilares C, Silva M, Rodrigues C, Costa M, Gordicho S, et al. Investigação sobre adesão à terapêutica na população portuguesa: uma revisão de âmbito [Research on medication adherence in the Portuguese population: a scoping review]. Rev Port Med Geral Fam. 2017;33(4):262-76. Portuguese
Sousa S, Pires A, Conceição C, Nascimento T, Grenha A, Braz L. Polimedicação em doentes idosos: adesão à terapêutica [Polypharmacy in elderly patients: treatment adherence]. Rev Port Med Geral Fam. 2011;27(2):176-82. Portuguese
Spertus JA, Jones PG, Sandhu AT, Arnold SV. Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review. J Am Coll Cardiol. 2020;76(20):2379-90.
Niklasson A, Maher J, Patil R, Sillén H, Chen J, Gwaltney C, et al. Living with heart failure: patient experiences and implications for physical activity and daily living. ESC Heart Fail. 2022;9(2):1206-15.
Ordem dos Médicos. Juramento de Hipócrates. Available from: https://ordemdosmedicos.pt/wp-content/uploads/2017/08/Juramento_de_Hip%C3%B3crates.pdf
Botelho F, Silva C, Cruz F. Epidemiologia explicada: viéses [Explained epidemiology: bias]. Acta Urol. 2010;27(3):47-52. Portuguese
Rice H, Say R, Betihavas V. The effect of nurse-led education on hospitalisation, readmission, quality of life and cost in adults with heart failure: a systematic review. Patient Educ Couns. 2018;101(3):363-74.
Coelho BM, Santiago LM. Medicina centrada na pessoa: validação populacional de um instrumento de medida pela pessoa [Person-centered medicine: validation of a person perception instrument]. Rev Port Med Geral Fam. 2022;38(3):247-56. Portuguese
Spertus JA, Jones PG. Kansas City Cardiomyopathy Questionnaire-12 (KCCQ-12) [homepage]. Eprovide – Mapi Research Trust; 2015. Available from: https://eprovide.mapi-trust.org/instruments/kansas-city-cardiomyopathy-questionnaire-12
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Portuguese Journal of Family Medicine and General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.